Dementia and Alzheimer Disease

March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.

Ten general and disease-specific apps for neurologists include assessment scales, anatomical diagrams, and interactive clinical decision support.

Research included the impact of diet on cognitive decline and the degree of a link between depression & dementia post intracerebral hemorrhage.

February news includes stroke risk with Alzheimer disease & migraine, neonatal hemorrhagic stroke, and head trauma in sports.

Although sauna bathing can be beneficial in cardiovascular disease, how does the practice impact dementia and Alzheimer disease?

January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.

Could marijuana use increase the risk of developing Alzheimer disease?

From Alzheimer disease to Zika virus, we’ve compiled a list of this year’s most popular articles on Neurology Times.

Research from AES 2016 explored relationships between epilepsy and other neurological disorders, including Alzheimer disease, MS, stroke, and autism.

November news includes the first human clinical trial focusing on tau in Alzheimer disease and Zika-related microcephaly not presenting at birth.

Is loneliness predictive of preclinical Alzheimer disease? Dr. Lazzara discusses a study of cortical amyloid burden and loneliness in older adults.

November news includes potential Alzheimer treatments, FDA approval of a device to prevent recurrent stroke, & a newly typified headache disorder.

Dr. Lazzara reports on a study examining the effects of exercise on the cognitive function of older adults with mild cognitive impairment.

Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.

Dr. Bobby Lazzara reports on a clinical trial of aducanumab, a human monoclonal antibody, in patients with prodromal or mild Alzheimer disease.

Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.

Why is a lower BMI linked to greater dementia risks in the elderly? Dr. Bobby Lazzara discusses a recent analysis using the Harvard Aging Brain Study.

Our August news includes a potential classification system for Alzheimer disease, new findings in a 3D model of TBI, and migraine treatments.

Recent neurological studies outline a link between TBI and Parkinson disease, discuss neuroimaging to predict recovery, and warn against DIY tDCS.

Dr. Bobby Lazzara discusses the first description of reversal of cognitive decline in early Alzheimer disease or its precursors.

Our July news includes the Alzheimer-diabetes link, increased rates of Parkinson, and guidelines for acute migraine treatment in the ED.

In this Medical News Minute, Dr. Bobby Lazzara discusses a recent finding on Alzheimer disease and chromosome Y in men.

Investigators questioned whether cognitive tests could predict driving ability in people with Alzheimer disease and mild cognitive impairment.

Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.

Neuropsychiatric symptoms are commonly associated with mild cognitive impairment, but does amyloid pathology play a role in this relationship?